Propafenone Hydrochloride (Rythmol) is a potent Class Ic antiarrhythmic agent, but its use is associated with a range of potential side effects.

I. Major Side Effects of Propafenone Hydrochloride

1. Common Adverse Reactions (Incidence >5%)

(1) Mainly involve the gastrointestinal tract, central nervous system, and cardiovascular system, including: taste disturbance, nausea and/or vomiting, dizziness, constipation, headache, fatigue, first-degree atrioventricular block, and intraventricular conduction delay.

(2) Among these, taste disturbance, nausea/vomiting, dizziness, and constipation are the primary reasons leading to drug discontinuation.

2. Serious Adverse Reactions Requiring Vigilance

(1) Proarrhythmic effects: This is one of the most serious risks.

(2) Heart failure: The drug has negative inotropic effects and may induce or worsen heart failure, especially in patients with underlying cardiac disease.

(3) Cardiac conduction disturbances: May cause or worsen conduction blocks, such as second- or third-degree atrioventricular block, sinus bradycardia, bundle branch block, etc. Therefore, it should not be used in patients with sick sinus syndrome or conduction block without a pacemaker.

(4) Agranulocytosis: May occur within the first 2 months of treatment, presenting as a sharp decline in white blood cell count, increasing infection risk. Patients should report any unexplained fever, sore throat, or chills to their doctor immediately.

3. Other Reported Adverse Reactions

Other less common but noteworthy reactions include: blurred vision, dyspnea, palpitations, tremor, loss of appetite, diarrhea, ataxia, rash, abnormal liver function, and positive antinuclear antibodies (ANA), etc.

II. Strategies for Managing and Mitigating Side Effects

1. Prevention and Initial Management

(1) Individualized dose titration: Physicians typically start with a low dose (e.g., 150 mg every 8 hours) and gradually increase based on response, which helps reduce early adverse reactions.

(2) Avoid contraindications and at-risk populations: Ensure absence of contraindications such as heart failure, severe conduction block, bradycardia, Brugada syndrome, etc., before use.

(3) Manage drug interactions: Actively inform your doctor of all medications you are taking, especially CYP2D6 (e.g., paroxetine) and CYP3A4 (e.g., ketoconazole, erythromycin) inhibitors that affect drug metabolism, as well as drugs that may be affected like digoxin and warfarin.

2. Monitoring and Response During Treatment

(1) Close ECG monitoring: Regular ECG monitoring must be performed before and during treatment to assess changes in PR interval and QRS duration, as well as for new arrhythmias.

(2) Timely symptom reporting: Inform your doctor of any unusual feelings.

(3) Emergency management of serious reactions: If symptoms such as difficulty breathing, severe dizziness, fainting, worsening palpitations, or swelling in the limbs (potentially indicating heart failure or serious arrhythmia) occur, stop taking the drug immediately and seek emergency medical help.

III. Proper Storage of Propafenone Hydrochloride

1. Storage Temperature

Store the medication in an environment at 20°C to 25°C.

2. Storage Environment Requirements

(1) Tablets should be kept in their original light-resistant, well-sealed container to protect against light and moisture that could affect efficacy.

(2) Always tighten the cap securely after each use.

3. Safe Storage

Always store all medications out of the reach of children to prevent accidental ingestion.